2 7 Word count: 192/200 2 8 Autosomal dominant North Carolina macular dystrophy (NCMD) is believed to represent 2 9 a failure of macular development. The disorder has been assigned by linkage to two loci, 3 0 MCDR1 on chromosome 6q16 and MCDR3 on chromosome 5p15-p13. Recently, non-3 1 coding variants upstream of PRDM13 and a large duplication including IRX1 have been 3 2
1 0 2 and 13 were linked to MCDR1 7,9 , with family 13 recently found to carry the SNV V2 Haplotype sharing analysis was carried out using the Homozygosity Haplotype (HH) 1 1 7 method 18 to search for shared identical-by-descent (IBD) chromosomal segments among 1 1 8 affected individuals within each family. This analysis was performed in those families for 1 1 9
which Illumina single-nucleotide polymorphism (SNP) array data were available for 1 2 0 more than one affected family member (families 1-5 and 12-13). The 6q16 MCDR1 locus 1 2 1 was excluded in four families, including the two previously MCDR3-linked families 1 14 1 2 2 and 2 11 and unreported families 3 and 4 (Supplementary Figs. S2-S5). Family 5 showed 1 2 3 evidence for haplotype sharing at many regions across the genome, including both the 1 2 4 6q16 and 5p15-p13 loci ( Supplementary Fig. S6 ). The two previously reported MCDR1-1 2 5 linked families 12 7 and 13 9 were confirmed with evidence for a Region with a Conserved reported V2 family 13 15 , two more NCMD families were found to harbour the variant V2 1 3 5 (family 11 and the previously described MCDR1-linked family 12 7 ). first identified SV by 85% of the sequence (GRCh37/hg19 chr5:4396925-4436534).
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Subsequently, members from families 4-7 were also found to carry the same 43 kb 1 6 1 duplication.
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PCR primers were designed to amplify the novel sequence across the breakpoint between 1 6 3 duplicated copies (Table 2, Fig. 3 ) and used to confirm the predicted breakpoints and 1 6 4 assess segregation of the two variants in all available affected and unaffected members of 1 6 5 families 1 and 2 ( Fig. 3 , Table 1 and Supplementary Fig. S1 ). PCR was then used to 1 6 6 genotype the available affected individuals from families 3-7 and confirmed the presence 1 6 7 of a band in all affected individuals tested (Table 1 and Supplementary Fig. S1 ). The remaining 8 unmapped families were tested with the established PCR assay for both 1 7 2 duplications, and 3 of them (families 8-10) were also found to carry the 43 kb duplication 1 7 3 (Table 1 and Supplementary Fig. S1 ). Thus, a total of 9 not knowingly related families 1 7 4 were shown to harbour the same 43 kb tandem duplication at the MCDR3 locus. Five We hypothesized that finding the same 6q16 SNV and 5p15 duplication with identical 1 8 1 breakpoint in 3 and 9 families respectively, could be due to two different shared ancestral 1 8 2 haplotypes suggestive of a common founder, in keeping with previous reports on other 1 8 3 6q16 NCMD families 5, 12, 13, 15 . Therefore, haplotype sharing analysis was performed using We report two distinct heterozygous tandem duplications at the MCDR3 locus in 30 1 9 7 affected individuals from 10 NCMD families. The two novel SVs overlap the previously 1 9 8 described duplication found in a single NCMD family of Danish origin 15 and further 1 9 9 refine the 5p15 NCMD locus to a shared region of 39 kb in a gene desert downstream of 2 0 0 IRX1 and upstream of ADAMTS16 (800 kb and 693.9 kb from the respective transcription 2 0 1 start sites, Fig. 4 ).
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We postulated that the 39 kb shared region could harbour cis-acting elements that Supplementary Fig. S11 ). In contrast, 2 0 9 ADAMTS16 had medium expression levels throughout the retina 23, 24 . Although no role in 2 1 0 retinal pathophysiology has been described for ADAMTS16, the gene has high sequence 2 1 1 similarity to ADAMTS18 which has been previously associated with retinal disease 32 .
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Overall, the data suggest that the pattern and/or refined spatial dosage and timing of 2 1 3 expression of the transcription factor IRX1 may be important in macular development. A (Table 3) . Interestingly, one of the sites was active during three DHSs are turning off.
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As mentioned, the MCDR1 locus on chromosome 6q16 is associated with variants sited 2 2 6 within a DHS, which suggests that aspects of macular development may be highly gene 2 2 7 dosage sensitive. Exploring the function and precise target of such regulatory domains in 2 2 8 both loci will be essential for understanding the disease mechanism of NCMD and factor and histone methyltransferase PRDM13 29,30 was suggested as a disease mechanism 2 4 1 for NCMD at the 6q16 locus, based on the identification of non-coding SNVs and 2 4 2 duplication events residing in an overlapping region upstream of PRDM13 in many 2 4 3 MCDR1 families. Differential regulation of PRDM13 in eyecups derived from wild-type 2 4 4 iPSCs 15,16 was suggested. However, no causal relationship between the non-coding 2 4 5 variants and PRDM13 expression has been identified.
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Despite variable presentation in affected individuals, the NCMD phenotypic spectrum is 2 4 7 indistinguishable in patients assigned to either of the two linked loci, MCDR1 and 2 4 8 MCDR3. Whether a biological and functional connection between PRDM13 at the 2 4 9 MCDR1 locus and the most likely candidate gene IRX1 at the MCDR3 locus exists 2 5 0 warrants further investigation. iPSC technology and CRISPR manipulation in eye cups 2 5 1 from normal and affected individuals may help elucidate the molecular mechanism 33,34 2 5 2 and the potential molecular links between the two genes. Importantly, the involvement of 2 5 3 ancestral variation at both the 6q16 and 5p15 loci (Supplementary Figs. S9-S10) in such a 2 5 4 highly penetrant dominant disease is intriguing, with the implication that there may exist 2 5 5 a significant number of unrecognized related NCMD families. Full clinical examination 2 5 6 reveals a high degree of penetrance, but visually unaffected individuals in whole families 2 5 7 may fail to be ascertained.
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Finally, the two novel duplications identified in this study significantly further the 2 5 9 2 4 Table 2 Primer sequences used for the segregation analysis of the two novel MCDR3 duplications identified in the study. 
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